BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22692031)

  • 1. Self-assembling mini cell-penetrating peptides enter by both direct translocation and glycosaminoglycan-dependent endocytosis.
    Bode SA; Thévenin M; Bechara C; Sagan S; Bregant S; Lavielle S; Chassaing G; Burlina F
    Chem Commun (Camb); 2012 Jul; 48(57):7179-81. PubMed ID: 22692031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis.
    Bechara C; Pallerla M; Zaltsman Y; Burlina F; Alves ID; Lequin O; Sagan S
    FASEB J; 2013 Feb; 27(2):738-49. PubMed ID: 23070606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
    Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
    J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary conformational conversion is involved in glycosaminoglycans-mediated cellular uptake of the cationic cell-penetrating peptide PACAP.
    Tchoumi Neree A; Nguyen PT; Chatenet D; Fournier A; Bourgault S
    FEBS Lett; 2014 Dec; 588(24):4590-6. PubMed ID: 25447531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of glycosaminoglycan binding and clustering to the biological uptake of the nonamphipathic cell-penetrating peptide WR9.
    Ziegler A; Seelig J
    Biochemistry; 2011 May; 50(21):4650-64. PubMed ID: 21491915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head to tail cyclisation of cell-penetrating peptides: impact on GAG-dependent internalisation and direct translocation.
    Amoura M; Illien F; Joliot A; Guitot K; Offer J; Sagan S; Burlina F
    Chem Commun (Camb); 2019 Apr; 55(31):4566-4569. PubMed ID: 30931466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosaminoglycans are required for translocation of amphipathic cell-penetrating peptides across membranes.
    Pae J; Liivamägi L; Lubenets D; Arukuusk P; Langel Ü; Pooga M
    Biochim Biophys Acta; 2016 Aug; 1858(8):1860-7. PubMed ID: 27117133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct translocation of cell-penetrating peptides in liposomes: a combined mass spectrometry quantification and fluorescence detection study.
    Walrant A; Matheron L; Cribier S; Chaignepain S; Jobin ML; Sagan S; Alves ID
    Anal Biochem; 2013 Jul; 438(1):1-10. PubMed ID: 23524021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classes and prediction of cell-penetrating peptides.
    Lindgren M; Langel U
    Methods Mol Biol; 2011; 683():3-19. PubMed ID: 21053118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive glycosaminoglycan-dependent entry of Trp-containing cell-penetrating peptides induced by exogenous sphingomyelinase or cholesterol depletion.
    Bechara C; Pallerla M; Burlina F; Illien F; Cribier S; Sagan S
    Cell Mol Life Sci; 2015 Feb; 72(4):809-20. PubMed ID: 25112713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.
    Kamide K; Nakakubo H; Uno S; Fukamizu A
    Int J Mol Med; 2010 Jan; 25(1):41-51. PubMed ID: 19956900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionpair-π interactions favor cell penetration of arginine/tryptophan-rich cell-penetrating peptides.
    Walrant A; Bauzá A; Girardet C; Alves ID; Lecomte S; Illien F; Cardon S; Chaianantakul N; Pallerla M; Burlina F; Frontera A; Sagan S
    Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183098. PubMed ID: 31676372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamics of lipid interactions with cell-penetrating peptides.
    Sauder R; Seelig J; Ziegler A
    Methods Mol Biol; 2011; 683():129-55. PubMed ID: 21053127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation of cell-penetrating peptides across the plasma membrane is controlled by cholesterol and microenvironment created by membranous proteins.
    Pae J; Säälik P; Liivamägi L; Lubenets D; Arukuusk P; Langel Ü; Pooga M
    J Control Release; 2014 Oct; 192():103-13. PubMed ID: 25016968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
    Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
    J Control Release; 2011 Jul; 153(2):163-72. PubMed ID: 21536086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular partners for interaction and cell internalization of cell-penetrating peptides: how identical are they?
    Walrant A; Bechara C; Alves ID; Sagan S
    Nanomedicine (Lond); 2012 Jan; 7(1):133-43. PubMed ID: 22191782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.
    Verdurmen WP; Bovee-Geurts PH; Wadhwani P; Ulrich AS; Hällbrink M; van Kuppevelt TH; Brock R
    Chem Biol; 2011 Aug; 18(8):1000-10. PubMed ID: 21867915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Penetrating Ability of Peptide Hormones: Key Role of Glycosaminoglycans Clustering.
    Neree AT; Nguyen PT; Bourgault S
    Int J Mol Sci; 2015 Nov; 16(11):27391-400. PubMed ID: 26580613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating peptides: 20 years later, where do we stand?
    Bechara C; Sagan S
    FEBS Lett; 2013 Jun; 587(12):1693-702. PubMed ID: 23669356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosaminoglycans in the cellular uptake of drug delivery vectors - bystanders or active players?
    Favretto ME; Wallbrecher R; Schmidt S; van de Putte R; Brock R
    J Control Release; 2014 Apr; 180():81-90. PubMed ID: 24548480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.